Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 135


Improvement of the association between self-reported pill count and varenicline levels following exclusion of participants with misreported pill count: A commentary on Peng et al. (2017).

Peng AR, Le Foll B, Morales M, Lerman C, Schnoll R, Tyndale RF.

Addict Behav. 2018 Apr;79:14-16. doi: 10.1016/j.addbeh.2017.11.032. Epub 2017 Dec 2.


Novel CYP2A6 diplotypes identified through next-generation sequencing are associated with in-vitro and in-vivo nicotine metabolism.

Tanner JA, Zhu AZ, Claw KG, Prasad B, Korchina V, Hu J, Doddapaneni H, Muzny DM, Schuetz EG, Lerman C, Thummel KE, Scherer SE, Tyndale RF.

Pharmacogenet Genomics. 2018 Jan;28(1):7-16. doi: 10.1097/FPC.0000000000000317.


Genome-wide association study of a nicotine metabolism biomarker in African American smokers: impact of chromosome 19 genetic influences.

Chenoweth MJ, Ware JJ, Zhu AZX, Cole CB, Cox LS, Nollen N, Ahluwalia JS, Benowitz NL, Schnoll RA, Hawk LW Jr, Cinciripini PM, George TP, Lerman C, Knight J, Tyndale RF; PGRN-PNAT Research Group.

Addiction. 2018 Mar;113(3):509-523. doi: 10.1111/add.14032. Epub 2017 Nov 2.


Measures and predictors of varenicline adherence in the treatment of nicotine dependence.

Peng AR, Morales M, Wileyto EP, Hawk LW Jr, Cinciripini P, George TP, Benowitz NL, Nollen NL, Lerman C, Tyndale RF, Schnoll R.

Addict Behav. 2017 Dec;75:122-129. doi: 10.1016/j.addbeh.2017.07.006. Epub 2017 Jul 12.


No Effect of Commercial Cognitive Training on Brain Activity, Choice Behavior, or Cognitive Performance.

Kable JW, Caulfield MK, Falcone M, McConnell M, Bernardo L, Parthasarathi T, Cooper N, Ashare R, Audrain-McGovern J, Hornik R, Diefenbach P, Lee FJ, Lerman C.

J Neurosci. 2017 Aug 2;37(31):7390-7402. doi: 10.1523/JNEUROSCI.2832-16.2017. Epub 2017 Jul 10.


Sleep Disturbance During Smoking Cessation: Withdrawal or Side Effect of Treatment?

Ashare RL, Lerman C, Tyndale RF, Hawk LW, George TP, Cinciripini P, Schnoll RA.

J Smok Cessat. 2017 Jun;12(2):63-70. doi: 10.1017/jsc.2016.11. Epub 2016 Apr 12.


Does cannabis use moderate smoking cessation outcomes in treatment-seeking tobacco smokers? Analysis from a large multi-center trial.

Rabin RA, Ashare RL, Schnoll RA, Cinciripini PM, Hawk LW Jr, Lerman C, Tyndale RF, George TP.

Am J Addict. 2016 Jun;25(4):291-6. doi: 10.1111/ajad.12382. Epub 2016 May 17.


Racial differences in the relationship between rate of nicotine metabolism and nicotine intake from cigarette smoking.

Ross KC, Gubner NR, Tyndale RF, Hawk LW Jr, Lerman C, George TP, Cinciripini P, Schnoll RA, Benowitz NL.

Pharmacol Biochem Behav. 2016 Sep;148:1-7. doi: 10.1016/j.pbb.2016.05.002. Epub 2016 May 11.


Nicotine withdrawal alters neural responses to psychosocial stress.

Ashare RL, Lerman C, Cao W, Falcone M, Bernardo L, Ruparel K, Hopson R, Gur R, Pruessner JC, Loughead J.

Psychopharmacology (Berl). 2016 Jul;233(13):2459-67. doi: 10.1007/s00213-016-4299-5. Epub 2016 Apr 18.


Translational Research on Nicotine Dependence.

Falcone M, Lee B, Lerman C, Blendy JA.

Curr Top Behav Neurosci. 2016;28:121-50. doi: 10.1007/7854_2015_5005. Review.


Precision Medicine for Tobacco Dependence: Development and Validation of the Nicotine Metabolite Ratio.

Allenby CE, Boylan KA, Lerman C, Falcone M.

J Neuroimmune Pharmacol. 2016 Sep;11(3):471-83. doi: 10.1007/s11481-016-9656-y. Epub 2016 Feb 12. Review.


Brain Responses to Smoking Cues Differ Based on Nicotine Metabolism Rate.

Falcone M, Cao W, Bernardo L, Tyndale RF, Loughead J, Lerman C.

Biol Psychiatry. 2016 Aug 1;80(3):190-7. doi: 10.1016/j.biopsych.2015.11.015. Epub 2015 Nov 26.


RNA sequencing of transcriptomes in human brain regions: protein-coding and non-coding RNAs, isoforms and alleles.

Webb A, Papp AC, Curtis A, Newman LC, Pietrzak M, Seweryn M, Handelman SK, Rempala GA, Wang D, Graziosa E, Tyndale RF, Lerman C, Kelsoe JR, Mash DC, Sadee W.

BMC Genomics. 2015 Nov 23;16:990. doi: 10.1186/s12864-015-2207-8.


Transcranial Direct Current Brain Stimulation Increases Ability to Resist Smoking.

Falcone M, Bernardo L, Ashare RL, Hamilton R, Faseyitan O, McKee SA, Loughead J, Lerman C.

Brain Stimul. 2016 Mar-Apr;9(2):191-6. doi: 10.1016/j.brs.2015.10.004. Epub 2015 Oct 23.


Decreased Nicotinic Receptor Availability in Smokers with Slow Rates of Nicotine Metabolism.

Dubroff JG, Doot RK, Falcone M, Schnoll RA, Ray R, Tyndale RF, Brody AL, Hou C, Schmitz A, Lerman C.

J Nucl Med. 2015 Nov;56(11):1724-9. doi: 10.2967/jnumed.115.155002. Epub 2015 Aug 13.


Drug Metabolizing Enzyme and Transporter Gene Variation, Nicotine Metabolism, Prospective Abstinence, and Cigarette Consumption.

Bergen AW, Michel M, Nishita D, Krasnow R, Javitz HS, Conneely KN, Lessov-Schlaggar CN, Hops H, Zhu AZ, Baurley JW, McClure JB, Hall SM, Baker TB, Conti DV, Benowitz NL, Lerman C, Tyndale RF, Swan GE; Transdisciplinary Research in Cancer of the Lung Research Team.

PLoS One. 2015 Jul 1;10(7):e0126113. doi: 10.1371/journal.pone.0126113. eCollection 2015.


The Nicotine Metabolite Ratio is Associated With Early Smoking Abstinence Even After Controlling for Factors That Influence the Nicotine Metabolite Ratio.

Chenoweth MJ, Schnoll RA, Novalen M, Hawk LW Jr, George TP, Cinciripini PM, Lerman C, Tyndale RF.

Nicotine Tob Res. 2016 Apr;18(4):491-5. doi: 10.1093/ntr/ntv125. Epub 2015 Jun 11.


Nicotine metabolite ratio (3-hydroxycotinine/cotinine) in plasma and urine by different analytical methods and laboratories: implications for clinical implementation.

Tanner JA, Novalen M, Jatlow P, Huestis MA, Murphy SE, Kaprio J, Kankaanpää A, Galanti L, Stefan C, George TP, Benowitz NL, Lerman C, Tyndale RF.

Cancer Epidemiol Biomarkers Prev. 2015 Aug;24(8):1239-46. doi: 10.1158/1055-9965.EPI-14-1381. Epub 2015 May 26.


Lack of Associations of CHRNA5-A3-B4 Genetic Variants with Smoking Cessation Treatment Outcomes in Caucasian Smokers despite Associations with Baseline Smoking.

Tyndale RF, Zhu AZ, George TP, Cinciripini P, Hawk LW Jr, Schnoll RA, Swan GE, Benowitz NL, Heitjan DF, Lerman C; PGRN-PNAT Research Group.

PLoS One. 2015 May 26;10(5):e0128109. doi: 10.1371/journal.pone.0128109. eCollection 2015.


Initial Evaluation of Fenofibrate for Efficacy in Aiding Smoking Abstinence.

Perkins KA, Karelitz JL, Michael VC, Fromuth M, Conklin CA, Chengappa KN, Hope C, Lerman C.

Nicotine Tob Res. 2016 Jan;18(1):74-8. doi: 10.1093/ntr/ntv085. Epub 2015 Apr 20.

Supplemental Content

Loading ...
Support Center